inVentiv Health's Campbell Alliance Launches Consulting Services in Japan for Clients Seeking Commercial Expertise and Support in Asia
Pawel Komender Appointed Regional General Manager to Lead the New Tokyo Office
BURLINGTON, Mass. and TOKYO, JAPAN – March 27, 2014 – Campbell Alliance, an inVentiv Health company and industry leader in biopharmaceutical consulting, today announced the launch of its consulting business in Japan and the opening of its Tokyo office. Campbell’s presence in Tokyo complements a dozen other locations in North America and Europe where inVentiv has on-the-ground consulting services.
The opening of the consulting office allows inVentiv to act as a strategic partner for any biopharmaceutical company conducting business in Asia. The Japanese office will offer all the services and expertise clients count on from inVentiv, including:
- Market Assessment and Opportunity Identification
- Pricing and Market Access
- Market Entry and Go-to-Market Strategy
- Product Launch
- Commercial Excellence and
- In- and Out-Licensing.
The Campbell Alliance office in Asia will operate as inVentiv Health Consulting.
“inVentiv Health Consulting will provide in–market capabilities and presence for U.S.-based companies looking to better understand the Japanese market,” said Darius Naigamwalla, President of Campbell Alliance. “For Japanese clients wanting Japan-based support, we will provide local presence and accessibility. The office also will round out our industry-leading global Pricing and Market Access Capabilities, as well as offer seamless delivery of solutions to support all aspects of product development and commercialization. Our focus is on helping clients solve intricate problems, optimize emerging opportunities and succeed in an evolving marketplace."
In leading the new office, Pawel Komender will leverage nearly 20 years of professional experience in Japan and a track record of assignments in the Asia Pacific region. Prior to joining Campbell Alliance, Mr. Komender worked with Accenture Japan and Simon-Kucher & Partners. He is fluent in Japanese, English, German, and Polish.
“Pawel’s background in strategic consulting and his deep functional knowledge, as well as his experience working in the Japanese market, make him the ideal person to lead our consulting business and our anticipated growth in Japan,” Naigamwalla said.
For further information about inVentiv Health Consulting in Japan, please visit the Campbell Alliance website at http://www.campbellalliance.com/Japan/.
About Campbell Alliance
Campbell Alliance is the Consulting business segment of inVentiv Health and an industry leader in biopharmaceutical consulting. The firm's clients include all of the world's top-20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into three Centers of Excellence—Commercial, Medical, and Corporate Development—each of which offers a range of services to a critical area of the pharmaceutical and biotechnology industries. Each of our Centers of Excellence is a dedicated consulting team whose members are highly specialized and offer deep expertise in their chosen areas. From its 13 office locations, the firm serves clients throughout North America, Europe, and Asia. For more information on Campbell Alliance, please visit www.campbellalliance.com.
About inVentiv Health
inVentiv Health, Inc., is a life science knowledge and services company purpose-built for the new healthcare marketplace. inVentiv has created a new model by converging a vast range of essential services to fully align with our client’s development and commercialization goals. With more than 12,000 employees supporting clients in 70 countries, our global scale and broad expertise make us an attractive strategic partner for companies seeking to get medicines to patients in a complex operating, regulatory and reimbursement environment. inVentiv Health’s clients include more than 550 life sciences companies, including all 20 of the largest biopharmaceutical companies in the world. inVentiv Health, Inc. is privately owned by inVentiv Group Holdings, Inc., an organization sponsored by affiliates of Thomas H. Lee Partners, L.P., Liberty Lane Partners and members of the inVentiv management team. inVentiv Health transforms promising ideas into commercial reality for the financial success of our clients and the delivery of better treatments to patients worldwide. For more information, visit http://www.inVentivHealth.com.